||Research ||Specialty Pharmaceutical Industry - 2011 Yearbook
Company's Specialty Pharmaceutical Industry - 2011 Yearbook” essentially
provides insights on specialty pharmaceutical sales and price forecasts until
2017. The report provides in-depth therapeutics analysis of eight niche
indications, namely: Human Immunodeficiency Virus (HIV)/Acquired immune
deficiency syndrome (AIDS), age related macular degenerative disorders,
attention deficit hyperactivity disorder (ADHD), Alzheimer’s disease,
colorectal cancer, rheumatoid arthritis, epilepsy and glaucoma, including
their annual cost of therapy (ACT) and revenue. In addition, the geographical
distribution of these disorders therapies across the US, the top five countries
in the European region and Japan are also provided in the report. The report
also includes insights into the specialty pharmaceutical Research and
Development (R&D) pipeline and the potential future blockbusters up to
2017. Furthermore, it also covers the market forecasts and treatment usage
patterns of these eight therapeutic indications up to 2017. Finally, the key
trend analysis on Mergers and Acquisitions (M&A), licensing agreements and
co-development deals involving specialty pharmaceuticals is also presented.
The report covers -
- Annualized market data for the specialty pharmaceutical market from 2001
to 2009, with forecasts to 2017.
- Market analysis for the eight major indications in the global specialty
pharmaceutical market which includes HIV/AIDS, age related macular
degenerative disorder, attention deficit hyperactivity disorder (ADHD),
Alzheimer’s disease, colorectal cancer, rheumatoid arthritis, epilepsy and
- Data and analysis on the specialty pharmaceutical market in the leading
geographies of the world – the US, the UK, Germany, France, Italy, Spain, and
- Market data on the geographical landscape and therapeutic landscape,
including market size, market share, annual cost of therapy, sales volume and
treatment usage patterns such as disease population, treatment seeking
population, diagnosis population and prescription population.
- Key M&A activities and licensing agreements that took place from 2004 to
2010 in the specialty pharmaceutical market.
Browse complete Report on :